Effect of diabetes mellitus on cardiac resynchronization therapy and to prognosis in heart failure (from the Prospective Evaluation of Asian With Cardiac Resynchronization Therapy for Heart Failure Study)
The American Journal of Cardiology Jul 24, 2019
Tan ESJ, et al. - Researchers determined how cardiac resynchronization therapy (CRT) response and cardiovascular outcomes in Asian heart failure (HF) patients were influenced by diabetes mellitus (DM) in the Prospective Evaluation of Asian with CRT for Heart Failure study. Time to composite of HF-hospitalization and all-cause death was considered as the primary endpoint. The participants (n=161, age 66.7 ± 11.2 years, 22% females, mean QRS duration 154.3 ± 22.4 ms, 83% left bundle branch block) were observed for 3.3 ± 1.5 years. CRT responders and super-responders were 84 (52%) and 57 (35%) of the overall participants, respectively. The strongest predictor of event free survival was the extent of reverse remodeling after CRT. However, DM caused a reduction in reverse remodeling and induced end organ dysfunction, thereby affecting CRT recipients in a detrimental manner. Also, an independent link of DM with worsened clinical outcomes was found in Asian HF patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries